Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM
Season 5, Episode 10, Jun 14, 02:15 PM
In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.